Category: Technology
-
ImmunoPrecise (IPA.V): when scientific breakthrough is executed strategically
You know what grinds my gears? The fact that investors will happily speculate on Tesla (TSLA.NYSE) stock because they think they understand the automobile market, but won’t attempt to do the due diligence for biotechs because it’s “too hard”.
-
Biotech: Who will survive when the Covid-19 Hype Ends? Part II
For part I of this series please click here. Cities across Canada are gradually returning to business as usual, and we’re winning the fight against Covid-19 (don’t look south of the border). Thanks to all citizens still wearing hats to hide their botched home-haircuts, and our essential workers who literally put their lives on the…
-
Leaping Forward: PredictMedix (PMED.C) partners with TechMahindra
Keynes once said that “the market can remain irrational longer than you can remain solvent”. Fundamentals departed market valuation long ago, but you could’ve at least expected market reaction to be in response to COVID-19 related news. Except it seems like that’s no longer the case.
-
Fans Unite (FANS.C) to amalgamate with Askott Entertainment in $26m deal to build e-sports/sport betting giant
In baseball, the best trade between teams, it’s often been said, is one in which both teams think they got the better end of the deal. Today’s announcement between Fans Unite (FANS.C) and privately held but long considered public listing-bound Askott Entertainment appears to be just one of those deals. The pair have entered into…
-
![Predictmedix (PMED.C) killing it on new COVID-19 screening tech]()
Predictmedix (PMED.C) killing it on new COVID-19 screening tech
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days, on the back of news it’s being used by a large events company, and financials that show a very short road to profitability. For those that haven’t been paying attention…
-
Biotech: Who Will Survive When The COVID-19 Hype Ends?
Over the last couple of months, companies have found a way to muster up an effort to align their objectives with helping society recover from this global pandemic – COVID-19. The result: share prices have soared like never before. The line up of biotech companies trying to come up with COVID-19 vaccines or cures is…
-
![Patriot One (PAT.T) attracts $4.5 million Supercluster Covid-19 Funding]()
Patriot One (PAT.T) attracts $4.5 million Supercluster Covid-19 Funding
This proposed investment will fund the advanced development and deployment of the Patscan VRS health and safety detection modules for thermal elevated body temperature, facial mask screening, social distancing and contact tracing as part of the Company’s suite of video object recognition solutions.
-
![Predictmedix (PMED.C) inks deal to install COVID-19 Mass Screening Tech]()
Predictmedix (PMED.C) inks deal to install COVID-19 Mass Screening Tech
“Predictmedix’ best-in-class screening technology pairs perfectly with our ability to custom-fabricate quickly and efficiently,” states Jonathan Auger, CEO of Juiceworks Exhibits
-
![PredictMedix: Pharma Monopoly Meets Tech Growth]()
PredictMedix: Pharma Monopoly Meets Tech Growth
Here’s a simple and effective investment strategy: invest in companies that sell products with growing inelastic demand.
-
Last Mile Holdings (MILE.V): A micro-sized macro transport revolution just begging to be done right
Micro-mobility ride-sharing, which is the terminology that’s been coined for e-scooters, bike-shares, mopeds and the like, is clearly an idea that has a future. Small enough to park anywhere (we’ll get to the dark side of that in a second), cheap enough to mass produce, able to be electrified and charged easily, and tied to…
